Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8250989rdf:typepubmed:Citationlld:pubmed
pubmed-article:8250989lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:8250989lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8250989lifeskim:mentionsumls-concept:C0239946lld:lifeskim
pubmed-article:8250989lifeskim:mentionsumls-concept:C0025677lld:lifeskim
pubmed-article:8250989lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8250989lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:8250989pubmed:issue12lld:pubmed
pubmed-article:8250989pubmed:dateCreated1994-1-6lld:pubmed
pubmed-article:8250989pubmed:abstractTextTo evaluate the progression of hepatic fibrosis in patients with rheumatoid arthritis (RA) treated with methotrexate (MTX).lld:pubmed
pubmed-article:8250989pubmed:languageenglld:pubmed
pubmed-article:8250989pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8250989pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8250989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8250989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8250989pubmed:statusMEDLINElld:pubmed
pubmed-article:8250989pubmed:monthDeclld:pubmed
pubmed-article:8250989pubmed:issn0004-3591lld:pubmed
pubmed-article:8250989pubmed:authorpubmed-author:WardJ RJRlld:pubmed
pubmed-article:8250989pubmed:authorpubmed-author:TolmanK GKGlld:pubmed
pubmed-article:8250989pubmed:authorpubmed-author:BjorkmanD JDJlld:pubmed
pubmed-article:8250989pubmed:authorpubmed-author:CleggD ODOlld:pubmed
pubmed-article:8250989pubmed:authorpubmed-author:BoschertMMlld:pubmed
pubmed-article:8250989pubmed:issnTypePrintlld:pubmed
pubmed-article:8250989pubmed:volume36lld:pubmed
pubmed-article:8250989pubmed:ownerNLMlld:pubmed
pubmed-article:8250989pubmed:authorsCompleteYlld:pubmed
pubmed-article:8250989pubmed:pagination1697-701lld:pubmed
pubmed-article:8250989pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:meshHeadingpubmed-meshheading:8250989-...lld:pubmed
pubmed-article:8250989pubmed:year1993lld:pubmed
pubmed-article:8250989pubmed:articleTitleThe effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.lld:pubmed
pubmed-article:8250989pubmed:affiliationDivision of Gastroenterology, University of Utah College of Medicine, Salt Lake City.lld:pubmed
pubmed-article:8250989pubmed:publicationTypeJournal Articlelld:pubmed